Introduction
============

Bacterial pathogens are known to possess sophisticated mechanisms for their survival within their hosts by expressing specific products. These products, called virulence factors, are involved in the steps of infectious process, resulting in host-pathogen interaction.[@B1][@B2] The outcome of this complex and dynamic interaction is manifested as signs and symptoms of clinical infectious diseases. In cases of root canal and periapical infections, it is widely accepted that anaerobic Gram-negative bacteria are responsible.[@B3][@B4][@B5] However, the specific roles of putative bacterial pathogens in the pathogenesis of endodontic infections have not yet been adequately assessed. Of these putative pathogens, *Enterococcus faecalis* (*E. faecalis*) has been implicated to play an important role in persistent root canal and periapical infections mainly due to its unique presence in these lesions.[@B6][@B7]

At present, molecular pathogenesis of *E. faecalis* infection is not well understood, since the virulence factors involved in root canal and periapical infections have not yet been adequately identified or characterized. Several putative virulence factors of *E. faecalis* with potential of pathogenicity have been described, including aggregation substance, several surface adhesions, sex pheromones, lipoteichoic acid, gelatinase, hyaluronidase, extracellular superoxide production, and bacteriocins.[@B8] However, their exact roles in endodontic infections have not yet been determined since it is unclear whether these virulence factors are involved in the actual disease process. Additional virulence factors from *E. faecalis* need be identified and characterized to better understand the interactions between this microorganism and the host since they mediate the infectious activities in root canal and periapical infection.

Most traditional bacterial virulence factors have been identified using an *in vitro* approach in the laboratory. It is well established that these virulence factors may not be involved in the actual disease process since they are not even expressed inside the host.[@B9] It is therefore crucial to identify and/or characterize genes (proteins) expressed *in vivo* instead of using an *in vitro* approach, since these *in vivo* expressed genes (proteins) are more likely to serve as virulence factors. Numerous molecular techniques have been developed for identifying bacterial genes and their products expressed only in the host, including *in vivo* expression technology, signature-tagged mutagenesis, differential fluorescence induction, transcriptional and proteomic profiling, and *in vivo*-induced antigen technology (IVIAT).[@B10][@B11][@B12][@B13][@B14][@B15]

Change-mediated antigen technology (CMAT), a modification of IVIAT, is an antibody-based screening technique used to identify bacterial antigens expressed only *in vivo* when bacteria undergo changes such as an infection.[@B16] This technology uses hyperimmune antisera raised against bacterial cells isolated from infected tissues. The hyperimmune antisera are subsequently adsorbed with cells and extracts of cells that grow *in vitro* to produce a probe that is reactive only with proteins expressed exclusively *in vivo*. CMAT has not been used to identify antigens of *E. faecalis* expressed *in vivo*. Therefore, the objective of this study was to use CMAT to screen and identify *in vivo*-expressed antigens of *E. faecalis* using an experimental animal infection model.

Materials and Methods
=====================

Bacterial strains and growth conditions
---------------------------------------

*E. faecalis* ATCC 29212 was purchased from American Type Culture Collection (Manassas, VA, USA) and grown on Brain heart infusion (BHI) agar (Becton Dickson, Sparks, MD, USA) at 37℃. For broth growth, bacterial cells were incubated in 10 mL of BHI broth for 12 hours at 37℃. Cell pellets were collected and kept at -80℃ until used. *E. coli* BL21 (DE3)/pLysS competent cells (Stratagene, La Jolla, CA, USA) were grown overnight on lysogeny broth (LB) agar plates or in LB broth containing kanamycin (30 µg/mL) at 37℃.

Construction of genomic expression libraries of *E. faecalis* 29212
-------------------------------------------------------------------

Genomic DNA from *E. faecalis* cells were extracted using a G-spin Genomic DNA Extraction Kit for Bacteria (iNtRON Biotechnology, Sungnam, Korea) according to manufacturer\'s instructions. Purified genomic DNA was then randomly sheared by sonication using a SONOPULS Ultrasonic homogenizer (Bandelin, Berlin, Germany) for 6 seconds at 100% power set of Sonic to generate DNA fragments sized of 1 - 5 kb. After fractionated by agarose gel electrophoresis to remove fragments that were smaller than 1 kb or bigger than 5 kb, DNA fragments of 1 - 5 kb were treated with End-It DNA End-Repair Kit (Epicentre, Madison, WI, USA) and subjected to phenol-chloroform extraction to eliminate any T4 polynucleokinase activity. Expression vector pET-30c (+) (Novagen, Madison, WI, USA) was digested with *EcoR*V, purified with QIAquick PCR Purification Kit (Qiagen, Valencia, CA, USA), and dephosphorylated with APex heat-labile alkaline phosphatase (Epicentre). A total of 250 ng of pET-30c (+)/*EcoR*V and blunt-ended *E. faecalis* DNA fragments at size of 1 - 5 kb were ligated at various molar ratios of vector to insert DNA (1:0.5, 1:1, 1:2, 1:5, and 1:10) using T4 DNA ligase (New England Biolab, Ipswich, MA, USA). The ligated mixture was used to transform *E. coli* DH5α (Takara, Daejon, Korea). Transformants were selected on LB plates containing kanamycin antibiotics. A total of 10 colonies were randomly selected and screened using colony PCR with T7 promoter primers. The frequency of self-ligation was lower than 20%. Purified recombinant DNA mixture was used to transform *E. coli* BL21 (DE3)/pLysS Competent Cells (Stratagene). Transformed cells were grown at 37℃ overnight on LB agar plates containing kanamycin (30 µg/mL).

Experimental endodontic infection
---------------------------------

Animal experimental protocols were reviewed and approved by the Institutional Animal Care and Use Committee, Chonnam National University (approval number: YB-2011-19). All surgical procedures were performed under sterile conditions. One 3 year old male beagle dog with weight of 10 kg was used for this study. Anesthetic induction was achieved by intravenous administration of thiopental (13.2 mg/kg body weight) followed by administration of 1 - 2% of isoflurane via an endotrachial tube. Additional local anesthesia of 2% lidocaine hydrochloride with 1:100,000 epinephrine was used to give a regional block. Preoperative radiograph was taken to determine any existing periodontal or endodontic lesion. After the induction, the second, third, and fourth premolars of each side of the upper jaw were used for inducing experimental endodontic infection as follows. A high-speed handpiece equipped with a round bur with saline irrigation was used to perforate a buccal surface of each tooth until it reached the pulp tissue. A total of 1.5 × 10^5^ *E. faecalis* cells were then injected into the pulp cavity using an insulin syringe to induce endodontic infection. The access opening on the buccal surface was subsequently covered with light-cured composite materials. After the surgical procedure, analgesic medication (3 mg/kg body weight, Ketopro, Unibiotech Co., Yesan, Korea) was administered for three days.

Three weeks after injecting bacterial cells into the pulp, a radiograph was taken again to assess the status of periapical lesion of infected teeth. At this time, the dog was anesthetized again using the same protocol described above. All infected premolars were extracted and hemisectioned. Infected pulp and root canal tissues were removed using a barbed broach. They were immediately dissolved in phosphate buffered saline (PBS). Bacterial cell pellets were obtained by centrifugation at ×4,000 g for 20 minutes as described previously.[@B17] Purified cell pellets were immediately stored in -20℃. They were sent to a commercial vendor (Young In Frontier Co., Seoul, Korea) to produce hyperimmune antisera in rabbits. Based on optical density, it was determined that the bacterial cell pellets contained more than 5 × 10^9^ cells. The presence of *E. faecalis* was confirmed by visual inspection under a light microscope and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. The efficacy of produced antibodies was monitored by the enzyme-linked immunosorbent assay (ELISA) analysis.

Serum adsorption
----------------

To obtain a serum probe that reacted only to *in vivo* expressed *E. faecalis* antigens, hyperimmune rabbit sera were adsorbed with *E. faecalis* cells cultivated *in vitro*. Adsorptions were performed using whole bacterial cells. First, rabbit polyclonal antiserum was mixed with 1 × 10^9^ *E. faecalis* cells with slow agitation (30 rpm) at 4℃ for 1 hour. Cells were removed by centrifugation at ×5,000 g for 10 minutes and the serum (supernatant) was recovered. This step was repeated 4 times. After centrifugation, adsorbed serum was retrieved and stored at -80℃ until used. Cell lysates bound to nitrocellulose membrane were added into serum after removing whole cells and agitated overnight at 4℃. The serum was collected the next day. To remove antibodies that bound to *E. coli* proteins, the serum was agitated again with nitrocellulose membrane-bound *E. coli* BL21 harboring pET-30c(+) vector only.

To determine the adsorption efficiency, ELISA was performed as described previously.[@B18] Briefly, a 96-well plate was coated with *E. faecalis* crude protein extracts at a concentration of 0.1 mg/100 mL in a coating buffer (0.1 M sodium carbonate, pH 9.6) overnight at 4℃. After washing, a blocking solution (2% skim milk in PBS, 300 µL) was added and incubated at 37℃ for 1 hour, followed by washing with PBS. The adsorbed rabbit antisera was added to each well using a serial dilution starting from 1:1,000 dilution and incubated at 37℃ for 2 hours. After the incubation, the plate was washed three times with 1X Tris buffered saline and Tween (TBS-Tween). Then, 50 mL of 1:10,000 diluted goat anti-human IgG conjugated with horse radish peroxidase (Abcam, Hanam, Korea) was added to each well and incubated at 37℃ for 1 hour. After washing the wells three times with TBS-Tween solution, TMB solution (GenDEPOT, Barker, TX, USA) was added to each well. After incubating at room temperature for 2 minutes, the reaction was stopped by adding 1 N H~2~SO~4~ (100 mL). Absorbance was measured at 450 nm using a 96-well plate reader (spectrometer).

Genomic library screening for *E. faecalis* proteins uniquely expressed *in vivo*
---------------------------------------------------------------------------------

*E. coli* recombinant clones were screened using the adsorbed hyperimmune rabbit sera as described previously.[@B19] Briefly, kanamycin-resistant *E. coli* clones (approximately 200 per plate) were transferred to a nitrocellulose membrane. *In vivo* grown *E. faecalis* and *E. coli* containing pET-30c (+) were spotted onto the membrane as positive and negative control for screening, respectively. The membrane was then transferred (colony side up) to a LB agar plate containing 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) to induce protein expression. After incubation at 37℃ for 3 hours, the membrane was removed and the attached cells were lysed by exposure to chloroform vapor. The membrane was then blocked with 5% skim milk in PBS for 1 hour, washed with PBS-Tween 20, and incubated overnight with the adsorbed rabbit hyperimmune serum (1:500) at 4℃. After the incubation, the membrane was washed and probed with goat anti-rabbit IgG conjugated with horse radish peroxidase (1:1,000) at room temperature for 1 hour. A 1-step chloronaphthol (4CN, Thermo Scientifc, Waltham, MA, USA) was used as substrate to identify reactive clones. Positive clones showing reactivity were isolated from the original (master) plate. They were grown on LB-kanamycin plates. Their reactivity was confirmed again using a 4CN as substrate.

Identification of genes isolated by CMAT
----------------------------------------

Plasmid DNAs from positive clones were purified using a QIAprep Spin Miniprep Kit (Qiagen, Valencia, CA, USA). DNA sequences of inserted DNA fragments from *E. faecalis* were determined by direct sequencing using a T7 promoter primer with an ABI Prism 377 automatic DNA sequencer by double-strand dideoxy chain termination method at GenoTech Corp. (Daejeon, Korea). Identified gene sequences were compared to DNA and protein databases using a BLAST program (<http://www.ncbi.nlm.nih.gov>) and analyzed by Vector NTI Software (Invitrogen, Carlsbad, CA, USA). Functional classification of identified antigens was based on published studies of identified proteins of *E. faecalis* if available.

Results
=======

Adsorption of rabbit hyperimmune antisera
-----------------------------------------

SDS-PAGE analysis confirmed the presence of bacterial cells in the sample acquired from experimental endodontic infection ([Figure 1](#F1){ref-type="fig"}). The hyperimmune rabbit antisera produced against *E. faecalis* infected pulp and periapical tissues were successively adsorbed against *E. faecalis* cells grown *in vitro*. The adsorption efficiency was determined by examining immuno-reactivity of antisera using ELISA after each adsorption step with *in vitro* grown *E. faecalis*. Fully adsorbed serum exhibited a significant lower reactivity to *in vitro* grown *E. faecalis* ([Figure 2](#F2){ref-type="fig"}), suggesting that the adsorption process efficiently removed antibodies against most *E. faecalis* proteins produced during *in vitro* cultivation.

Genomic library construction and screening
------------------------------------------

Plasmid DNAs of ten colonies randomly selected from the library were subjected to direct DNA sequencing to confirm the presence of the DNA inserts present in the recombinant plasmids. Of the 10 colonies, eight had DNA inserts in the pET-30c (+) vector. A total of approximately 4,500 recombinant clones were screened using the adsorbed pooled serum. *In vivo* grown *E. faecalis* cells and *E. coli* cells containing only pET-30c (+) placed on the nitrocellulose membrane was used as positive and negative control, respectively, for the immunoscreening. Initial screening resulted in the detection of 30 immuno-reactive clones. Of the 30 clones, nineteen reproducibly exhibited reactivity with the adsorbed serum. Therefore, they were subjected to further DNA sequencing.

Identification and functional classification of *E. faecalis* genes identified by CMAT
--------------------------------------------------------------------------------------

Sequencing of the DNA inserts of the 19 positive clones revealed 16 open reading frames (ORFs). Sequences of the remaining three clones could not be obtained. Sequences of the 16 clones were analyzed using BLAST program. CMAT-identified *in vivo*-induced genes and their predicted functions are listed in [Table 1](#T1){ref-type="table"}. Many determined gene sequences contained portions of ORFs for putative genes. The size of ORF varied from 663 bp to 2,911 bp. In addition, multiple ORFs were not identified. Sequence analysis revealed that many of these ORFs were enzymes implicated in housekeeping functions with intermediary metabolism. In addition, conserved hypothetical proteins with unknown function and putative membrane protein were also identified, along with copper resistance proteins.

Discussion
==========

Very limited information regarding the nature of virulence factors of *E. faecalis* has hampered our understanding of the mechanisms by which this endodontic pathogen interacts with the host and ultimately leads to endodontic infection. Considering that genes (proteins) expressed *in vivo* are very likely to be important in the microorganisms\' ability to survive in the host and/or serve as virulence factors, our major objective was to identify *E. faecalis* proteins that were uniquely expressed *in vivo* during the actual infectious process. For this purpose, we adopted a new technique called CMAT designed to detect immunoreactive proteins exhibiting specificity only to *in vivo*-induced proteins. For this immunoscreening, we needed to prepare a \'probe\' antibody that reacts only to *in vivo*-induced proteins (not proteins produced *in vitro*). CMAT is a modification of the IVIAT that has enabled many investigators to identify *in vivo*-induced proteins directly from the human host rather than from a potentially misleading animal model.[@B15][@B19] IVIAT has been successfully used to study pathogens such as *Candida albicans*, *Vibrio cholera*, *Mycobacterium tuberculosis*, *Vibrio vulnificus*, *Escherichia coli*, *Salmonella enterica*, Group A *Streptococcus*, and periodontal pathogens including *Aggregatibacter actinomycetemcomitan*, *Porphyromonas gingivalis*, and *Tannerella forsythia*.[@B18][@B20][@B21][@B22][@B23][@B24][@B25][@B26][@B27][@B28] However, the use of IVIAT requires high antibody titers in human sera against the etiological agents, it may not be readily applicable to the study of microorganisms that do not induce strong humoral responses in humans. Therefore, CMAT was specifically developed to address the above limitation of IVIAT.

The original design of this study was to use *E. faecalis* samples from clinical cases of pulp and endodontic infection from human subjects. However, we failed to secure adequate amount of *E. faecalis* cells from clinical cases that could induce sufficient humoral immune responses (data not shown). Therefore, as an alternative, we adopted an animal model using a beagle dog for the purpose of producing *in vivo*-grown *E. faecalis* cells. In this model, pulp tissues were intentionally infected with *E. faecalis* cells in hopes of causing endodontic infection. From the lesions of pulp and root canal infections, we were able to collect adequate amount of *E. faecalis* cells for the CMAT purpose.

In this pilot study, we used CMAT to identify more than a dozen protein antigens that were reactive with adsorbed antisera reactive with *in vivo*-grown *E. faecalis* cells. To the best of our knowledge, this is the first attempt to identify *in vivo*-induced proteins from *E. faecalis*. One of the advantages of using CMAT is that it does not require an efficient genetic manipulation system nor human infection because it can utilize an alternative animal model.

Many *in vivo*-induced genes of *E. faecalis* identified by CMAT included several enzymes related to housekeeping functions, including energy metabolism, translation, amino acid biosynthesis, and other cellular process ([Table 1](#T1){ref-type="table"}). These genes were similar to those identified by previous IVIAT studies.[@B18][@B29] These genes might play roles that are not required for *in vitro* growth.[@B30] It has been observed that \'housekeeping\' genes are not constitutively expressed at the transcriptional level in bacteria as previously assumed, indicating that housekeeping metabolism as a very dynamic process is extremely capable of adapting to different growth conditions.[@B31][@B32][@B33] Therefore, it is plausible that these genes are up-regulated and expressed only *in vivo*.

A copper resistance protein was identified in this study. Although its exact function is unknown, it has been found in other bacteria including *E. coli*, *Pseudomonas syringae*, and *Xanthomonas axonopodis*.[@B34] Considering metallic copper can act as antimicrobial surface, copper resistance could function as a potential virulence factor.[@B35] CMAT was able to identify several putative membrane proteins. Since little is known regarding the functions of membrane protein in *E. faecalis*, analysis of these *in vivo* induced proteins identified in this study may increase our understanding on the pathogenic mechanisms of this microorganism.

Further use of CMAT in *E. faecalis* will be required to identify additional *in vivo* induced proteins that are likely to be important in survival in the host and may serve as virulence factors in the disease process. In future studies, the functional roles of these identified genes can be tested by constructing isogenic mutants for use in animal models or *in vitro* models. These efforts will ultimately allow us to gain a better insight into the pathogenic mechanisms of *E. faecalis*. For example, gene expression (mRNA) analysis using real-time PCR for each identified gene could be performed to confirm its *in vivo* expression.[@B18][@B36] Genetic analysis using isogenic mutant (such as siRNA-knockdown or gene destruction) could be performed to confirm the identified genes (proteins) are really related to the disease process, as previously performed.[@B37][@B38]

Once functional roles are confirmed to be important for *E. faecalis* virulence, these virulence factors could be analyzed as candidates for diagnostic, therapeutic, and preventive measures for endodontic infections. Identified virulence factors could be used as disease markers for pulpal and peri-apical infection associated with *E. faecalis*. The presence of these virulence factors in the pulp and periaplical tissues will confirm the infectious disease process mediated by *E. faecalis* without bacterial culture of the clinical samples. Another potential application includes the development of therapeutic and preventive approaches targeting these virulence factors, such as intracanal medication, vaccines, and novel antimicrobial substances.[@B22] By specifically inactivating virulence factors without affecting other non-virulent components, it would be possible to effectively inhibit or reduce virulence mediated by *E. faecalis*. These efforts will lead to improved management of persistent endodontic infections associated with *E. faecalis*.

Conclusions
===========

Sixteen *in vivo*-induced proteins of *E. faecalis* were identified using CMAT and experimental endodontic infection model. These proteins were expressed uniquely *in vivo* and reactive with sera produced against *in vivo*-grown *E. faecalis*. The results of this pilot study suggest that CMAT adopting an experimental animal model of endodontic infection is a useful approach to identify and characterize potential virulence factors of *E. faecalis*. Detailed analysis of these *in vivo*-induced genes (proteins) will lead to a better understanding of the molecular mechanisms involved in the endodontic infection of *E. faecalis*.
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![Confirmation of bacterial antigens by SDS-PAGE. In lanes 4 - 6, different amount of bacterial cell pellets were loaded. SDS-PAGE, sodium dodecyl sulphate-polyacrylamide gel electrophoresis; BSA, bovine serum albumin.](rde-40-306-g001){#F1}

![Testing an efficacy of the adsorption procedure for hyperimmune rabbit antisera against *E. faecalis* whole cell pellets by ELISA analysis. Adsorbed serum exhibited a significant decrease of the reactivity. ELISA, enzyme-linked immunosorbent assay.](rde-40-306-g002){#F2}

###### *E. faecalis* protein antigens identified by CMAT

![](rde-40-306-i001)

  GenBank Protein ID   Protein name                                  Function
  -------------------- --------------------------------------------- -------------------------
  AFA92809.1           Deoxyribose-phosphate aldolase                Energy metabolism
  AEA94635.1           Selenide, water dikinase                      Energy metabolism
  ADX80204.1           Beta-glucosidase                              Energy metabolism
  AA079953.1           Oxidoreductase                                Energy metabolism
  PF08503.3            Tetrahydrodipicolinate N-acetyltransferase    Energy metabolism
  ADX80368.1           3-ketoacyl-(acyl-carrier-protein) reductase   Energy metabolism
  AEA93036.1           Diaminopimelate epimerase                     Energy metabolism
  AEA92693.1           DNA topoisomerase subunit A                   Transcription
  EF62_0348            rRNA-23S ribosomal RNA                        Transcription
  AEA93730.1           Translation initiation factor IF2             Transcription
  ADX79467.1           Alanine racemase                              Amino acid biosynthesis
  AEA95149.1           Response regulator sensor histidine kinase    Cellular process
  ACF94631.1           Copper resistance protein                     Energy metabolism
  AA080103.1           Putative membrane protein                     Outer membrane protein
  ADX79209.1           Conserved hypothetical protein                Unknown
  ADX81283             Conserved hypothetical protein                Unknown
